Skip to main content

Gene Therapy – Detailed Notes


Gene Therapy – Detailed Notes


Definition

Gene therapy is a therapeutic technique in which genetic material (DNA or RNA) is introduced, removed, or modified in a patient’s cells to treat or prevent genetic disorders and diseases by correcting defective genes or providing new functional genes.

Basic Concept

Many diseases occur due to mutation, deletion, or malfunction of genes.
Gene therapy aims to:
Replace a defective gene
Add a functional gene
Silence or inhibit a harmful gene
It works at the molecular level, targeting the root cause of disease rather than symptoms.


Types of Gene Therapy


1. Somatic Gene Therapy

Gene transfer into somatic (body) cells.
Effects are not inherited.
Most widely used and ethically accepted.
Examples:
Cystic fibrosis, cancer therapy, SCID

2. Germline Gene Therapy
Gene transfer into germ cells (sperm/egg) or early embryos.
Genetic changes are heritable.
Ethically restricted and banned in many countries.
Approaches of Gene Therapy
1. Gene Replacement Therapy
Defective gene is replaced by a normal functional gene.
2. Gene Addition Therapy
A new gene is added without removing the defective one.
3. Gene Silencing Therapy
Harmful gene expression is suppressed using:
siRNA
antisense oligonucleotides
CRISPR interference

4. Gene Editing

Precise correction of genes using:
CRISPR-Cas9
TALENs
Zinc-finger nucleases
Delivery Methods of Gene Therapy

A. Viral Vectors

Viruses modified to be non-pathogenic and used as gene carriers.
Vector
Features
Applications
Retrovirus
Integrates into genome
Cancer, SCID
Lentivirus
Infects dividing & non-dividing cells
HIV, genetic disorders
Adenovirus
High expression, non-integrating
Cancer therapy
AAV
Low immunogenicity
Eye and muscle diseases
B. Non-Viral Methods
Liposomes (lipofection)
Electroporation
Naked DNA injection
Gene gun (biolistics)

Strategies of Gene Delivery

1. Ex Vivo Gene Therapy
Cells removed from patient
Genetically modified in laboratory
Reintroduced into patient
Example: SCID treatment

2. In Vivo Gene Therapy

Gene directly delivered into patient’s body
Example: Eye gene therapy (retinal disorders)
Steps Involved in Gene Therapy
Identification of defective gene
Cloning of therapeutic gene
Selection of suitable vector
Gene delivery to target cells
Expression of therapeutic gene
Monitoring for safety and efficacy


Applications of Gene Therapy

1. Genetic Disorders
Severe Combined Immunodeficiency (SCID)
Hemophilia
Cystic fibrosis
Muscular dystrophy
2. Cancer
Tumor suppressor gene delivery (p53)
Suicide gene therapy
Immunogene therapy
3. Infectious Diseases
HIV gene therapy
Hepatitis
4. Neurological Disorders
Parkinson’s disease
Alzheimer’s disease

Advantages

Treats disease at genetic level
Long-lasting or permanent cure
Highly specific
Reduces dependency on drugs
Potential to cure inherited disorders


Limitations

Immune response against vectors
Risk of insertional mutagenesis
High cost
Ethical concerns
Limited efficiency in some tissues
Ethical, Legal, and Social Issues
Germline gene therapy ethics
Gene editing in embryos
Accessibility and affordability
Long-term safety concerns
Genetic enhancement misuse


Recent Advances


CRISPR-Cas9 gene editing
CAR-T cell therapy
RNA-based therapies
Personalized gene therapy
Examples of Approved Gene Therapies
Luxturna – inherited retinal disease
Zolgensma – spinal muscular atrophy
CAR-T therapy – leukemia and lymphoma

Conclusion

Gene therapy represents a revolutionary approach in modern medicine, offering potential cures for genetic and chronic diseases. Although challenges such as safety, cost, and ethical issues remain, advances in gene editing and vector technology continue to improve its effectiveness and clinical success.



Gene therapy is used to:
A) Remove proteins
B) Modify genetic material
C) Destroy cells
D) Inhibit enzymes
Answer: B
Gene therapy treats disease by:
A) Drug action
B) Surgical removal
C) Correcting defective genes
D) Vaccination
Answer: C
Gene therapy acts at the:
A) Cellular level
B) Tissue level
C) Molecular level
D) Organ level
Answer: C
Genetic material used in gene therapy includes:
A) DNA only
B) RNA only
C) DNA or RNA
D) Proteins only
Answer: C
Replacement of a faulty gene is called:
A) Gene silencing
B) Gene replacement
C) Gene suppression
D) Gene knockout
Answer: B
Types of Gene Therapy
Gene therapy performed on body cells is called:
A) Germline gene therapy
B) Somatic gene therapy
C) Embryonic gene therapy
D) Reproductive gene therapy
Answer: B
Changes in somatic gene therapy are:
A) Heritable
B) Non-heritable
C) Permanent in offspring
D) Transmitted to next generation
Answer: B
Germline gene therapy affects:
A) Only patient
B) Only parents
C) Future generations
D) Cancer cells
Answer: C
Germline gene therapy is:
A) Widely accepted
B) Ethically restricted
C) Commonly practiced
D) Approved worldwide
Answer: B
Most current clinical gene therapy trials use:
A) Germline therapy
B) Somatic therapy
C) Embryonic therapy
D) Reproductive therapy
Answer: B
Approaches & Strategies
Addition of a normal gene without removing faulty one is:
A) Gene replacement
B) Gene addition
C) Gene deletion
D) Gene knockout
Answer: B
Suppression of harmful gene expression is called:
A) Gene addition
B) Gene silencing
C) Gene replacement
D) Gene activation
Answer: B
Tools used for gene editing include:
A) CRISPR-Cas9
B) TALENs
C) Zinc-finger nucleases
D) All of the above
Answer: D
Ex vivo gene therapy involves:
A) Direct injection into patient
B) Modification outside the body
C) Germline manipulation
D) Embryo editing
Answer: B
In vivo gene therapy involves:
A) Cell culture only
B) Direct delivery into patient
C) Gamete modification
D) Cloning
Answer: B
Vectors & Delivery Systems
Most commonly used vectors are:
A) Bacterial plasmids
B) Viral vectors
C) Ribosomes
D) Enzymes
Answer: B
Retroviral vectors integrate into:
A) Cytoplasm
B) Host genome
C) Mitochondria
D) Ribosomes
Answer: B
Lentiviruses can infect:
A) Dividing cells only
B) Non-dividing cells only
C) Both dividing and non-dividing cells
D) Bacterial cells
Answer: C
Adenoviral vectors generally:
A) Integrate into genome
B) Do not integrate into genome
C) Cause mutations always
D) Are non-immunogenic
Answer: B
AAV vectors are preferred because of:
A) High toxicity
B) Low immunogenicity
C) Large genome size
D) Rapid degradation
Answer: B
Non-Viral Methods
Liposome-mediated gene delivery is called:
A) Electroporation
B) Lipofection
C) Biolistics
D) Microinjection
Answer: B
Electroporation introduces DNA using:
A) Chemical treatment
B) Electric pulses
C) Heat shock
D) Ultrasound
Answer: B
Gene gun method is also called:
A) Lipofection
B) Microinjection
C) Biolistics
D) Transduction
Answer: C
Naked DNA delivery is mainly used in:
A) Muscles
B) Brain
C) Liver only
D) Kidney
Answer: A
Non-viral methods generally have:
A) Higher immunogenicity
B) Lower safety
C) Lower efficiency than viral vectors
D) Higher mutation rates
Answer: C
Applications
First successful gene therapy treated:
A) Hemophilia
B) SCID
C) Cystic fibrosis
D) Cancer
Answer: B
Gene therapy for cancer may involve:
A) Tumor suppressor genes
B) Suicide genes
C) Immune activation
D) All of the above
Answer: D
CAR-T cell therapy is used for:
A) Genetic disorders
B) Cancer treatment
C) Viral infection
D) Diabetes
Answer: B
Gene therapy in retinal disorders uses:
A) Retrovirus
B) Adenovirus
C) AAV
D) Lentivirus
Answer: C
Hemophilia gene therapy targets:
A) Clotting factor genes
B) Insulin genes
C) Antibody genes
D) Enzyme genes
Answer: A
Advantages
Main advantage of gene therapy is:
A) Temporary relief
B) Symptomatic treatment
C) Treats root cause of disease
D) Low cost
Answer: C
Gene therapy can provide:
A) Permanent cure
B) Short-term cure only
C) No cure
D) Temporary suppression only
Answer: A
Gene therapy reduces dependence on:
A) Surgery
B) Antibiotics
C) Long-term drug therapy
D) Vaccines
Answer: C
Target specificity of gene therapy is:
A) Low
B) Moderate
C) High
D) Random
Answer: C
Personalized medicine is possible due to:
A) Vaccines
B) Gene therapy
C) Antibiotics
D) Hormone therapy
Answer: B
Limitations & Ethics
Major risk of gene therapy is:
A) Infection
B) Insertional mutagenesis
C) Vitamin deficiency
D) Allergy only
Answer: B
Immune response occurs mainly against:
A) DNA
B) RNA
C) Viral vectors
D) Proteins
Answer: C
High cost is a:
A) Benefit
B) Ethical issue
C) Technical advantage
D) Safety feature
Answer: B
Germline gene therapy is controversial because it:
A) Is expensive
B) Affects future generations
C) Is inefficient
D) Requires viruses
Answer: B
Gene therapy trials require strict:
A) Laboratory rules
B) Ethical guidelines
C) Political approval
D) Trade regulations
Answer: B
Recent Advances & General
CRISPR-Cas9 is used for:
A) Gene cloning
B) Gene editing
C) Protein synthesis
D) DNA sequencing
Answer: B
RNA-based gene therapy includes:
A) siRNA therapy
B) mRNA therapy
C) Antisense therapy
D) All of the above
Answer: D
Zolgensma is approved for treating:
A) Cancer
B) Spinal muscular atrophy
C) Hemophilia
D) SCID
Answer: B
Luxturna is used to treat:
A) Muscular dystrophy
B) Retinal disease
C) Diabetes
D) Cancer
Answer: B
CAR-T therapy modifies:
A) B cells
B) T cells
C) Stem cells
D) Neurons
Answer: B
Final
Gene therapy is an example of:
A) Preventive medicine
B) Molecular medicine
C) Herbal medicine
D) Surgical therapy
Answer: B
Long-term expression in gene therapy requires:
A) Protein injection
B) Gene integration
C) Drug administration
D) Vaccination
Answer: B
Safety of gene therapy depends mainly on:
A) Vector choice
B) Age of patient
C) Diet
D) Temperature
Answer: A
Gene therapy is still limited by:
A) Technology
B) Ethical issues
C) Cost
D) All of the above
Answer: D
Future of gene therapy is closely linked with:
A) Antibiotics
B) Vaccines
C) Gene editing technologies
D) Herbal medicine
Answer: C





Comments

Post a Comment

Popular Posts

AFLP--Amplified Fragment Length Polymorphism

AFLP is a PCR-based DNA fingerprinting technique combining restriction digestion and selective PCR amplification of genomic DNA fragments. Developed by Vos et al., 1995. AFLP detects DNA polymorphisms at the genomic level and is highly reproducible and sensitive. Used in genetic mapping, diversity studies, phylogenetics, and marker-assisted selection. Principle AFLP relies on restriction digestion of genomic DNA, followed by ligation of adaptors and PCR amplification of a subset of fragments. Polymorphism arises due to variations in restriction sites, fragment length, insertions, or deletions. Key idea: Restriction digestion → Adaptor ligation → Selective amplification → Gel separation → Detection of polymorphic bands Materials Required Genomic DNA Restriction enzymes (usually EcoRI and MseI) Adaptors complementary to restriction sites PCR reagents: Taq polymerase, dNTPs, buffer, Mg²⁺ Primers complementary to adaptors with selective nucleotides Thermal cycler Polyacrylamide or agarose ...
Post a Comment
Read more

❥ Southern Blotting Notes

Southern Blotting  ❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥ 𓆞❥  Introduction Southern blotting is a molecular biology technique used for the detection of specific DNA sequences in a complex mixture of DNA. It was developed by Edwin M. Southern in 1975. The method involves restriction digestion of DNA, separation by gel electrophoresis, transfer (blotting) onto a membrane, and hybridization with a labeled DNA probe. Principle of Southern Blotting The technique is based on the principle of complementary base pairing. A single-stranded labeled DNA probe hybridizes specifically with its complementary DNA sequence immobilized on a membrane. Detection of the label confirms the presence and size of the target DNA fragment. Steps Involved in Southern Blotting. 1. Isolation of DNA Genomic DNA is extracted from cells or tissues. DNA must be pure and intact to ensure accurate results. 2. Restriction Enzyme  Digestion DNA is digested using specific restriction endonucleases. Produces DNA f...
1 comment
Read more

Secondary Databases (PROSITE, PRINTS, BLOCKS)

Secondary Databases (PROSITE, PRINTS, BLOCKS  Secondary Databases Introduction Biological databases are broadly classified into primary and secondary databases. Primary databases store raw experimental data (e.g., nucleotide or protein sequences), whereas secondary databases contain derived information obtained by analyzing primary sequence data. Secondary databases are mainly used to: Identify protein families Detect conserved motifs, patterns, and domains Predict protein function Study structure–function relationships Examples of secondary databases include PROSITE, PRINTS, BLOCKS, Pfam, etc. 1. PROSITE Database Definition PROSITE is a secondary database that documents protein domains, families, and functional sites in the form of patterns and profiles. Developed by Swiss Institute of Bioinformatics (SIB) Maintained along with UniProt Principle PROSITE is based on the idea that functionally important regions of proteins are conserved during evolution. These conserved regions can ...
Post a Comment
Read more

DNA-Mediated Gene Transfer – Detailed Notes

DNA-Mediated Gene Transfer – Detailed Notes 1. Definition DNA-mediated gene transfer refers to the direct introduction of exogenous DNA into a host cell’s genome or cytoplasm without using viral or bacterial vectors. It is a physical or chemical approach to achieve gene delivery. Also called direct gene transfer. 2 . Principle Foreign DNA is delivered into host cells through physical or chemical methods. DNA may integrate into the host genome (stable transformation) or remain episomal (transient expression). Expression depends on: DNA sequence and promoter Type of host cell Delivery efficiency 3. Types of DNA-Mediated Gene Transfer A. Physical Methods These methods use physical forces to introduce DNA into cells. Microinjection DNA is injected directly into the nucleus or cytoplasm using a glass micropipette. Used in: animal embryos, oocytes, plant protoplasts Advantages: Precise, can deliver large DNA fragments Limitations: Labor-intensive, requires specialized equipment, low throughp...
Post a Comment
Read more

Single Nucleotide Polymorphisms (SNPs) – Detailed Notes

Single Nucleotide Polymorphisms (SNPs) – Detailed Notes 1. Definition SNPs are single base-pair variations in the DNA sequence that occur at a specific position in the genome among individuals of a species. Example: At a specific locus, one individual may have A while another has G: Copy code Individual 1: …A T C G A T…   Individual 2: …A T C G G T… SNPs are the most common type of genetic variation in most organisms. 2. Characteristics of SNPs Single base change: Involves substitution of one nucleotide for another (A↔G, C↔T). Biallelic nature: Most SNPs have only two alleles in a population. Widespread in the genome: Found in coding regions (exons), non-coding regions (introns, promoters, intergenic regions). Stable inheritance: Passed from generation to generation like other genetic markers. Frequency: Occur approximately every 100–300 bp in the human genome. 3 . Types of SNPs SNPs are categorized based on location or effect on gene function: A. Based on genomic location Cod...
Post a Comment
Read more

SSR (Simple Sequence Repeat) Marker

SSR (Simple Sequence Repeat) Markers – Detailed Notes Introduction SSR markers, also called microsatellites, are short tandem repeats (1–6 bp) of DNA sequences found throughout the genome. Examples: (A)n, (CA)n, (GATA)n, where n is the number of repeat units. SSRs are highly polymorphic, co-dominant, and locus-specific, widely used in genetic mapping, variety identification, population genetics, and marker-assisted selection (MAS). SSRs are similar to STRs; in plants and animals, the term SSR is more commonly used in molecular breeding, while STR is used more in forensics and human genetics. Structure of SSR Repeat motif: 1–6 bp Number of repeats: Variable among individuals → basis of polymorphism Flanking regions: Conserved sequences used to design specific PCR primers SSR loci are generally abundant in non-coding regions, though some occur in genes. Principle SSR markers exploit variation in the number of repeat units at a specific locus. PCR amplification using primers flanking the...
Post a Comment
Read more

Protein Structure Database (PDB)

Protein Structure Database (PDB) Introduction The Protein Structure Database (PDB) is the primary global repository for the three-dimensional (3D) structures of biological macromolecules such as proteins, nucleic acids, and protein–ligand complexes. These structures are determined experimentally using techniques like X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, and Cryo-Electron Microscopy (Cryo-EM). PDB plays a vital role in understanding: Protein structure and function Molecular interactions Drug discovery and design Structural biology and bioinformatics History and Development Established in 1971 Founded by Brookhaven National Laboratory (USA) Initially contained only 7 protein structures Now maintained by the Worldwide Protein Data Bank (wwPDB) Members of wwPDB RCSB PDB (USA) PDBe (Europe) PDBj (Japan) BMRB (Biological Magnetic Resonance Data Bank) Objectives of PDB To collect, store, and distribute 3D structural data of biomolecules To provide free and ope...
Post a Comment
Read more

GEL RETARDATION ANALYSIS

GEL RETARDATION ANALYSIS (EMSA – Electrophoretic Mobility Shift Assay) Introduction Gel retardation analysis, also known as Electrophoretic Mobility Shift Assay (EMSA), is a widely used in vitro technique for studying DNA–protein and RNA–protein interactions. The method is based on the observation that a DNA–protein complex migrates more slowly than free DNA during non-denaturing gel electrophoresis, resulting in a mobility shift or “retardation”. EMSA is extensively used to study transcription factor binding, regulatory DNA elements, and binding specificity. Definition Gel retardation analysis (EMSA) is a technique used to detect and analyze binding interactions between nucleic acids and proteins by observing the reduced electrophoretic mobility of nucleic acid–protein complexes compared to free nucleic acids. Principle A labeled DNA or RNA probe is incubated with a specific binding protein. When binding occurs, a nucleic acid–protein complex is formed. This complex has a larger size ...
Post a Comment
Read more

Agrobacterium & CaMV-Mediated Gene Transfer –

Agrobacterium and CaMV-Mediated Gene Transfer – Detailed Notes 1. Introduction Gene transfer in plants is often achieved by exploiting natural genetic mechanisms of Agrobacterium tumefaciens and Cauliflower Mosaic Virus (CaMV). These systems allow stable introduction of foreign genes into plant genomes for transgenic plant development. 2. Agrobacterium-Mediated Gene Transfer 2.1 Definition Agrobacterium-mediated gene transfer uses the natural ability of Agrobacterium tumefaciens, a soil bacterium, to transfer a part of its DNA (T-DNA) into plant cells. T-DNA integrates into the plant nuclear genome, enabling stable transformation. 2.2 Mechanism Recognition and attachment Agrobacterium detects phenolic compounds secreted by wounded plant cells. These compounds activate virulence (vir) genes on the Ti (tumor-inducing) plasmid. Activation of vir genes VirA (sensor kinase) and VirG (response regulator) induce expression of other vir genes (VirB, VirC, VirD, VirE). T-DNA processing and tran...
Post a Comment
Read more

SCAR (Sequence Characterized Amplified Region) Markers

SCAR (Sequence Characterized Amplified Region) Markers   Introduction SCAR markers are PCR-based DNA markers derived from RAPD, AFLP, or other random markers. Developed by Paran and Michelmore in 1993 to convert dominant, less reproducible markers into specific, reproducible, co-dominant markers. SCAR markers are locus-specific, reproducible, and sequence-characterized, making them ideal for marker-assisted selection (MAS). Principle SCAR markers are designed based on known DNA sequences obtained from cloned RAPD/AFLP fragments. Specific primers (18–24 bp) are synthesized to amplify a single, defined locus. The PCR amplification of this region generates a distinct band, which is highly reproducible and can distinguish homozygotes from heterozygotes if designed as co-dominant. Key idea: Random marker (e.g., RAPD) → Cloning & sequencing → Design specific primers → PCR → SCAR marker Materials Required Genomic DNA from the organism Specific primers (18–24 bp) designed from sequence...
Post a Comment
Read more